BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24259030)

  • 1. Histological step sectioning of pelvic lymph nodes increases the number of identified lymph node metastases.
    Engvad B; Poulsen MH; Staun PW; Walter S; Marcussen N
    Virchows Arch; 2014 Jan; 464(1):45-52. PubMed ID: 24259030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective assessment of histological serial sectioning of pelvic lymph nodes in prostate cancer: a cost-benefit analysis.
    Schilling D; Hennenlotter J; Gakis G; Schwentner C; Kuehs U; Stenzl A; Sotlar K
    BJU Int; 2012 Sep; 110(6 Pt B):E166-71. PubMed ID: 22314026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.
    Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Mollenhauer M; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
    Eur Urol; 2014 Aug; 66(2):222-9. PubMed ID: 23465520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
    BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection.
    Altok M; Babaian K; Achim MF; Achim GC; Troncoso P; Matin SF; Chapin BF; Davis JW
    BJU Int; 2018 Jul; 122(1):66-75. PubMed ID: 29446205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular diagnostic tools for the detection of nodal micrometastases in prostate cancer patients undergoing radical prostatectomy with extended pelvic lymph node dissection: a prospective study.
    Vagnoni V; Schiavina R; Romagnoli D; Borghesi M; Passaretti G; Dababneh H; Concetti S; Martorana G
    Urologia; 2012 Dec; 79 Suppl 19():141-6. PubMed ID: 22865337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodal occult metastases in intermediate- and high-risk prostate cancer patients detected using serial section, immunohistochemistry, and real-time reverse transcriptase polymerase chain reaction: prospective evaluation with matched-pair analysis.
    Schiavina R; Capizzi E; Borghesi M; Vagnoni V; Romagnoli D; Rocca GC; Giunchi F; D'Errico A; De Giovanni A; Rizzi S; Brunocilla E; Martorana G; Fiorentino M
    Clin Genitourin Cancer; 2015 Apr; 13(2):e55-64. PubMed ID: 25212578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence-supported lymphography and extended pelvic lymph node dissection in robot-assisted radical prostatectomy: a prospective, randomized trial.
    Harke NN; Godes M; Wagner C; Addali M; Fangmeyer B; Urbanova K; Hadaschik B; Witt JH
    World J Urol; 2018 Nov; 36(11):1817-1823. PubMed ID: 29767326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of tumor cell burden by analysis of single cell lymph node disaggregates in metastatic prostate cancer.
    Schilling D; Hennenlotter J; Sotlar K; Kuehs U; Senger E; Nagele U; Boekeler U; Ulmer A; Stenzl A
    Prostate; 2010 Jul; 70(10):1110-8. PubMed ID: 20503396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patients.
    Conti A; Santoni M; Burattini L; Scarpelli M; Mazzucchelli R; Galosi AB; Cheng L; Lopez-Beltran A; Briganti A; Montorsi F; Montironi R
    World J Urol; 2017 Apr; 35(4):517-526. PubMed ID: 26694187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence Guided Targeted Pelvic Lymph Node Dissection for Intermediate and High Risk Prostate Cancer.
    Hruby S; Englberger C; Lusuardi L; Schätz T; Kunit T; Abdel-Aal AM; Hager M; Janetschek G
    J Urol; 2015 Aug; 194(2):357-63. PubMed ID: 25896557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer.
    Pargaonkar AS; Beissner RS; Snyder S; Speights VO
    Arch Pathol Lab Med; 2003 Jun; 127(6):701-5. PubMed ID: 12741893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
    Arenas LF; Füllhase C; Boemans P; Fichtner J
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node dissection combined with meticulous histology increases the detection rate of nodal metastases in prostate cancer.
    Staník M; Čapák I; Macík D; Vašina J; Lžičařová E; Jarkovský J; Šustr M; Miklánek D; Doležel J
    Int Urol Nephrol; 2014 Aug; 46(8):1543-9. PubMed ID: 24682846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Lymph Node Status for Prognostic Stratification of Prostate Cancer Patients Undergoing Radical Prostatectomy with Extended Pelvic Lymph Node Dissection.
    Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
    Clin Cancer Res; 2018 May; 24(10):2342-2349. PubMed ID: 29463560
    [No Abstract]   [Full Text] [Related]  

  • 16. How Image-Guided Pathology Can Improve the Detection of Lymph Node Metastases in Prostate Cancer.
    Schilham MGM; Küsters-Vandevelde H; Somford DM; Rijpkema M; Gotthardt M
    Clin Nucl Med; 2022 Jun; 47(6):559-561. PubMed ID: 35439175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic extended pelvic lymph node (LN) dissection as validation of the performance of [(11) C]-acetate positron emission tomography/computer tomography in the detection of LN metastasis in intermediate- and high-risk prostate cancer.
    Daouacher G; von Below C; Gestblom C; Ahlström H; Grzegorek R; Wassberg C; Sörensen J; Waldén M
    BJU Int; 2016 Jul; 118(1):77-83. PubMed ID: 26074275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More extended lymph node dissection template at radical prostatectomy detects metastases in the common iliac region and in the fossa of Marcille.
    Maderthaner L; Furrer MA; Studer UE; Burkhard FC; Thalmann GN; Nguyen DP
    BJU Int; 2018 May; 121(5):725-731. PubMed ID: 28834085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of sentinel node procedure for lymph node staging in prostate cancer patients at high risk for lymph node involvement.
    Van den Bergh L; Joniau S; Haustermans K; Deroose CM; Isebaert S; Oyen R; Mottaghy FM; Ameye F; Berkers J; Van Poppel H; Lerut E
    Acta Oncol; 2015 Jun; 54(6):896-902. PubMed ID: 25591936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
    Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
    BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.